A Clinical Study of the Effect of Enlicitide (MK-0616) Formulations in Healthy Participants (MK-0616-041)
Clinical trial NCT07481708 · COMPLETED
Trial details
- NCT number
- NCT07481708
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-03-23
- Primary completion
- 2026-05-18
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.